X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (406) 406
index medicus (354) 354
oncology (326) 326
female (201) 201
lung neoplasms - pathology (186) 186
article (185) 185
lung cancer (181) 181
male (180) 180
lung neoplasms - genetics (169) 169
cancer (154) 154
middle aged (138) 138
aged (125) 125
expression (110) 110
mutation (108) 108
lung neoplasms - metabolism (100) 100
cell line, tumor (96) 96
carcinoma, non-small-cell lung - genetics (95) 95
carcinoma, non-small-cell lung - pathology (93) 93
tumors (93) 93
adult (92) 92
prognosis (91) 91
animals (90) 90
immunohistochemistry (89) 89
adenocarcinoma (80) 80
mice (79) 79
cell biology (75) 75
gene expression regulation, neoplastic (75) 75
pathology (75) 75
adenocarcinoma - pathology (73) 73
adenocarcinoma - genetics (72) 72
respiratory system (72) 72
carcinoma (71) 71
lung neoplasms - drug therapy (70) 70
aged, 80 and over (66) 66
gene expression (60) 60
survival (60) 60
mutations (58) 58
carcinoma, non-small-cell lung - metabolism (56) 56
neoplasm staging (52) 52
genetic aspects (51) 51
breast-cancer (50) 50
respiratory tract diseases (48) 48
carcinoma, non-small-cell lung - drug therapy (47) 47
lung neoplasms - mortality (45) 45
research (44) 44
gene (41) 41
adenocarcinoma - metabolism (40) 40
analysis (38) 38
loss of heterozygosity (38) 38
activation (37) 37
carcinoma, squamous cell - genetics (37) 37
polymerase chain reaction (37) 37
disease-free survival (36) 36
apoptosis (35) 35
identification (35) 35
biology (34) 34
carcinoma, non-small-cell lung - mortality (34) 34
carcinoma, squamous cell - pathology (34) 34
proteins (34) 34
signal transduction (34) 34
biochemistry & molecular biology (33) 33
chemotherapy (33) 33
metastasis (33) 33
care and treatment (32) 32
gene expression profiling (32) 32
gene-expression (32) 32
genes (32) 32
gefitinib (31) 31
kaplan-meier estimate (31) 31
biomarkers, tumor - genetics (30) 30
dna methylation (30) 30
multidisciplinary sciences (30) 30
pathogenesis (30) 30
cell lung-cancer (29) 29
egfr (29) 29
growth-factor receptor (29) 29
lung cancer, non-small cell (29) 29
lung-cancer (29) 29
non-small cell lung cancer (29) 29
receptor, epidermal growth factor - genetics (29) 29
adenocarcinoma of lung (28) 28
biomarkers (28) 28
cell proliferation (28) 28
health aspects (28) 28
therapy (28) 28
treatment outcome (28) 28
abridged index medicus (27) 27
nsclc (27) 27
cells (26) 26
tumor cells, cultured (26) 26
biomarkers, tumor - analysis (25) 25
hematology, oncology and palliative medicine (24) 24
immunotherapy (24) 24
lung neoplasms - enzymology (24) 24
melanoma (24) 24
sensitivity (24) 24
settore med/27 - neurochirurgia (24) 24
squamous-cell carcinoma (24) 24
survival analysis (24) 24
adenocarcinoma - mortality (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 01/2014, Volume 20, Issue 2 Supplement, pp. IA11 - IA11
Journal Article
Lung Cancer, ISSN 0169-5002, 2016, Volume 99, pp. 79 - 87
Highlights • PD-1 pathway inhibitors have shown remarkable antitumor activity in NSCLC. • PD-L1 expression and mutational loads in tumor cells are predictive... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | PD-L1 | Immune checkpoint inhibition | Biomarker | NSCLC | PD-1 | PD-L1 EXPRESSION | TUMOR-IMMUNITY | UNTREATED MELANOMA | ANTI-PD-L1 ANTIBODY | ONCOLOGY | IMMUNOTHERAPY | RESPIRATORY SYSTEM | REGULATORY T-CELLS | SUPPRESSOR-CELLS | NIVOLUMAB | BLOCKADE | DRIVER MUTATIONS | Immunomodulation - drug effects | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Epithelial-Mesenchymal Transition - drug effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Epithelial-Mesenchymal Transition - genetics | Molecular Targeted Therapy | Biomarkers, Tumor | Tumor Microenvironment - genetics | Tumor Microenvironment - drug effects | Gene Expression | Carcinoma, Non-Small-Cell Lung - metabolism | Programmed Cell Death 1 Receptor - metabolism | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Agents, Immunological - pharmacology | Tumor Microenvironment - immunology | B7-H1 Antigen - metabolism | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Antineoplastic Agents, Immunological - therapeutic use | Epithelial-Mesenchymal Transition - immunology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Immune response | Lung cancer, Non-small cell | Biological markers | Gene expression
Journal Article
Cancer Cytopathology, 03/2013, Volume 121, Issue 3, pp. 109 - 110
Journal Article
JAMA, ISSN 0098-7484, 05/2014, Volume 311, Issue 19, pp. 1998 - 2006
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 09/2004, Volume 4, Issue 9, pp. 695 - 706
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2015, Volume 47, Issue 12, pp. 1475 - 1481
Tumors have high energetic and anabolic needs for rapid cell growth and proliferation(1), and the serine biosynthetic pathway was recently identified as an... 
ACTIVATION | PROTEIN | GLUTAMINE | PATHWAY | GLUCOSE | GROWTH | GENETICS & HEREDITY | GENE-EXPRESSION | IMPAIR | CARCINOMA | KEAP1 MUTATIONS | RNA, Small Interfering - genetics | NF-E2-Related Factor 2 - antagonists & inhibitors | Cell Proliferation | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Serine - biosynthesis | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Non-Small-Cell Lung - secondary | Biomarkers, Tumor - metabolism | NF-E2-Related Factor 2 - genetics | Adenocarcinoma - genetics | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | RNA, Messenger - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Blotting, Western | Xenograft Model Antitumor Assays | Animals | NF-E2-Related Factor 2 - metabolism | Biomarkers, Tumor - genetics | Mice | Adenocarcinoma - mortality | Apoptosis | Transcription factors | Cell metabolism | Development and progression | Genetic aspects | Genetic transcription | Lung cancer, Non-small cell | Properties | Health aspects | Medical research | Enzymes | Lung cancer | Biosynthesis | RNA polymerase | Metabolism | Gene expression | Experiments | Metabolites | Scientific imaging | Tumorigenesis | Labeling | Bioinformatics | Mass spectrometry
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 634 - 634
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4527 - 4527
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1105 - 1105
Journal Article
Nature Communications, ISSN 2041-1723, 10/2014, Volume 5, Issue 1, p. 5241
Journal Article
Nature Medicine, ISSN 1078-8956, 05/2017, Volume 23, Issue 5, pp. 551 - 555
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1493 - 1501
Journal Article